News

TAVR trial to assess alternative access sites


 

The alternative approaches also require additional equipment, and operators may be exposed to greater amounts of radiation. They may also lead to longer recovery and more incisional pain for patients, according to the societies.

Dr. Mack said that the trial will likely be completed in 6 months or less from its start date.

"Using registries for this kind of study has the potential to make new technology available in a timely manner while protecting patient safety," ACC Immediate Past President Dr. David Holmes said in a statement.

None of the physicians had relevant disclosures.

n.miller@elsevier.com

On Twitter @NaseemSMiller

Pages

Recommended Reading

Anticoagulant dabigatran ups the required dose of heparin
MDedge Cardiology
Further STEMI progress requires new focus
MDedge Cardiology
Depressed stroke survivors at increased risk of death
MDedge Cardiology
Orbital atherectomy boosted outcomes for calcified peripheral lesions
MDedge Cardiology
Pregnancy and Marfan: New insight into risks
MDedge Cardiology
Hybrid CFV endovenectomy promising, but not for the faint at heart
MDedge Cardiology
CDC: Address high smoking rate among mentally ill
MDedge Cardiology
Endovascular stroke treatments add nothing beyond IV TPA
MDedge Cardiology
No benefit of endovascular therapy added to TPA for stroke
MDedge Cardiology
Novel hemorrhagic stroke therapy bests medical management
MDedge Cardiology

Related Articles